HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nan Liu Selected Research

Transforming Growth Factor beta (TGF-beta)

1/2022The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor microenvironment.
1/2019TGF-beta/TGF-beta RII/CLC-3 axis promotes cognitive disorders in diabetes.
7/2018Gene expression profile analysis of U251 glioma cells with shRNA-mediated SOX9 knockdown.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nan Liu Research Topics

Disease

78Neoplasms (Cancer)
10/2022 - 10/2004
19Inflammation (Inflammations)
10/2021 - 04/2010
17Brain Ischemia (Cerebral Ischemia)
05/2021 - 06/2007
15Glioma (Gliomas)
12/2021 - 01/2011
14Neoplasm Metastasis (Metastasis)
03/2022 - 08/2005
13Breast Neoplasms (Breast Cancer)
12/2021 - 10/2007
12Stroke (Strokes)
05/2022 - 07/2011
12Infections
10/2020 - 01/2004
12Lung Neoplasms (Lung Cancer)
01/2018 - 08/2005
11Ischemic Stroke
01/2022 - 02/2014
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 10/2004
10Lymphatic Metastasis
01/2018 - 10/2004
10Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2018 - 06/2007
9Fibrosis (Cirrhosis)
01/2022 - 03/2014
9Aortic Dissection
01/2022 - 08/2010
9Myocardial Infarction
02/2021 - 11/2009
8Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
07/2022 - 12/2014
8Rheumatoid Arthritis
12/2021 - 01/2006
8Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 11/2009
7Ischemia
01/2022 - 07/2003
7Brain Injuries (Brain Injury)
12/2021 - 09/2015
7Experimental Arthritis
12/2021 - 08/2006
7Hypoxia (Hypoxemia)
01/2021 - 10/2010
7Infarction (Infarctions)
01/2019 - 06/2007
6Cerebral Infarction
01/2019 - 01/2008
5Spinal Cord Injuries (Spinal Cord Injury)
06/2022 - 11/2012
5Out-of-Hospital Cardiac Arrest
06/2022 - 01/2020
5Prostatic Neoplasms (Prostate Cancer)
04/2022 - 06/2012
5Acute Kidney Injury (Acute Renal Failure)
01/2022 - 06/2017
5COVID-19
01/2022 - 01/2021
5Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2022 - 03/2014
5Carcinoma (Carcinomatosis)
01/2021 - 02/2011
5Carcinogenesis
01/2020 - 10/2012
5Graves Disease (Basedow Disease)
02/2016 - 12/2009
4Pain (Aches)
06/2022 - 02/2018
4Wounds and Injuries (Trauma)
06/2022 - 11/2012
4Heart Arrest (Cardiac Arrest)
02/2022 - 06/2012
4Pancreatic Neoplasms (Pancreatic Cancer)
12/2021 - 05/2017
4Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 10/2012
4Chest Pain (Chest Pains)
01/2021 - 10/2016
4Hepatocellular Carcinoma (Hepatoma)
01/2021 - 08/2014
4Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 12/2012
4Adenocarcinoma of Lung
01/2019 - 12/2008
4Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017 - 10/2006
4Leukemia
06/2016 - 02/2002
3Liver Diseases (Liver Disease)
03/2022 - 12/2020
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 01/2014
3Non-alcoholic Fatty Liver Disease
01/2022 - 01/2021
3Sepsis (Septicemia)
12/2021 - 08/2015

Drug/Important Bio-Agent (IBA)

37Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2002
14Small Interfering RNA (siRNA)IBA
04/2022 - 05/2009
14Biomarkers (Surrogate Marker)IBA
03/2022 - 12/2012
12Biological ProductsIBA
03/2022 - 08/2005
12Pharmaceutical PreparationsIBA
01/2022 - 04/2013
12CytokinesIBA
12/2019 - 01/2009
11Interleukin-10 (Interleukin 10)IBA
12/2019 - 06/2007
10Messenger RNA (mRNA)IBA
01/2021 - 02/2002
9Peptides (Polypeptides)IBA
04/2022 - 12/2004
9MicroRNAs (MicroRNA)IBA
01/2021 - 10/2006
9salicylhydroxamic acid (SHAM)IBA
01/2018 - 02/2007
8MatrinesIBA
07/2022 - 12/2014
8Indicators and Reagents (Reagents)IBA
06/2022 - 08/2017
8DNA VaccinesIBA
12/2021 - 01/2009
7DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2002
7AntigensIBA
12/2021 - 01/2009
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 06/2009
6Neuroprotective AgentsIBA
01/2022 - 09/2015
6CollagenIBA
01/2022 - 11/2009
6RNA (Ribonucleic Acid)IBA
11/2021 - 08/2009
6omega-Chloroacetophenone (Mace)IBA
01/2021 - 08/2014
6Oxygen (Dioxygen)IBA
12/2019 - 07/2003
6Collagen Type II (Type II Collagen)IBA
09/2019 - 01/2006
6Therapeutic UsesIBA
01/2019 - 08/2006
6Delta CateninIBA
01/2018 - 04/2005
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2014
5Tissue Plasminogen Activator (Alteplase)FDA Link
01/2022 - 02/2014
5LipidsIBA
01/2022 - 01/2012
5VaccinesIBA
12/2021 - 08/2006
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2021 - 07/2003
5Long Noncoding RNAIBA
01/2021 - 01/2017
5ErbB Receptors (EGF Receptor)IBA
11/2020 - 01/2012
4CreatinineIBA
03/2022 - 08/2010
4Monoclonal AntibodiesIBA
01/2021 - 07/2010
4SuspensionsIBA
05/2020 - 09/2013
4Silicon Dioxide (Silica)FDA LinkGeneric
05/2020 - 03/2014
4Transcription Factors (Transcription Factor)IBA
01/2020 - 10/2016
4Doxorubicin (Adriamycin)FDA LinkGeneric
09/2018 - 12/2010
4beta CateninIBA
07/2009 - 08/2005
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2016
3ZincIBA
01/2022 - 01/2004
3Transforming Growth Factor beta (TGF-beta)IBA
01/2022 - 07/2018
3LigandsIBA
01/2022 - 06/2017

Therapy/Procedure

27Therapeutics
01/2022 - 01/2009
16Transplantation
05/2021 - 10/2007
7Length of Stay
04/2021 - 08/2015
6Immunotherapy
01/2022 - 02/2009
4Resuscitation
06/2022 - 06/2012
4Drug Therapy (Chemotherapy)
01/2021 - 07/2014
4Deep Hypothermia Induced Circulatory Arrest
01/2017 - 04/2007
3Castration
04/2022 - 06/2012